Name | Val-Cit-PAB-MMAE |
---|---|
Synonyms |
L-Ornithinamide, L-valyl-N-(aminocarbonyl)-N-[4-[(5S,8S,11S,12R)-12-[2-[(2S)-2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-oxoethy l]-4,10-dimethyl-5,8-bis(1-methylethyl)-11-[(1S)-1-methylpropyl]-3,6,9-trioxo-2,13-dioxa-4,7,10-triazatetradec-1-yl]phenyl]-
L-Valyl-N-{4-[(5S,8S,11S,12R)-11-[(2S)-2-butanyl]-12-(2-{(2S)-2-[(1R,2R)-3-{[(1S,2R)-1-hydroxy-1-phenyl-2-propanyl]amino}-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl}-2-oxoethyl)-5,8-diisopropyl-4, ;10-dimethyl-3,6,9-trioxo-2,13-dioxa-4,7,10-triazatetradec-1-yl]phenyl}-N-carbamoyl-L-ornithinamide |
Description | Val-Cit-PAB-MMAE is a drug-linker conjugate for ADC by using the anti-mitotic agent, monomethyl auristatin E (MMAE), linked via the peptide Val-Cit-PAB. |
---|---|
Related Catalog |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 1211.9±65.0 °C at 760 mmHg |
Molecular Formula | C58H94N10O12 |
Molecular Weight | 1123.427 |
Flash Point | 686.7±34.3 °C |
Exact Mass | 1122.705322 |
LogP | 4.80 |
Vapour Pressure | 0.0±0.3 mmHg at 25°C |
Index of Refraction | 1.552 |
Storage condition | 2-8℃ |